openPR Logo
Press release

Global Covid-19 Vaccine Market Demands, Size and Key Players Analysis AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc.

04-05-2021 08:35 AM CET | Health & Medicine

Press release from: ReportsnReports

Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by governments to procure the vaccine and the waves of infection is likely to drive the market growth during the forecast period.

Get Free Sample Copy of Global Covid-19 Vaccine Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4298838

Under the Patient Type segment, Covid-19 market for senior citizens is anticipated to witness the largest market share owing to the focus of the governments to vaccinate the vulnerable population, manufacturing of vaccines being outsourced and also manufacturers collaborating with hospitals and doctors to better understand their demand and meet their requirements will be pushing growth in the market for Covid-19 vaccine during the coming years.

Hospitals, followed by Clinics, Vaccination centers and Academic and research Institute will attain substantial market share as healthcare authorities and governments are trying their best to vaccinate the population to further avoid spread of coronavirus disease.

Among the regions, North America, followed by Europe and Asia Pacific, will experience remarkable growth owing to the second and third wave of spread of the virus, emergence of mutant viruses, presence of various leading global manufacturers in the region with companies ramping up their production capacity and growing number of coronavirus patients.

Scope of the Report
- The report analyses Covid-19 vaccine market By Value.
- The report analyses Covid-19 vaccine Market By Product Type (Multivalent Vaccine, Monovalent vaccine).
- The report analyses Covid-19 vaccine Market By Patient Type (Paediatric, Adult, Senior Citizens).
- The report further Covid-19 vaccine market By End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institute, Others).
- The Covid-19 vaccine Market has been analysed By Region (North America, Europe, and Asia Pacific) and By Country (United States, Canada, Germany, France, United Kingdom, Switzerland, Russia, China, Japan, India).
- The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, Product Type, Patient type and End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc.
- The report presents the analysis of Covid-19 vaccine market for the forecast period of 2025-2030.

Get 20% Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=4298838

Key Target Audience
- Covid-19 Vaccine Manufacturers
- Covid-19 vaccine Suppliers
- Hospitals, Vaccination Centers and Healthcare Units
- Consulting and Advisory Firms
- Investment Banks and Equity Firms

Table of Contents:

1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
3. Covid-19 Vaccine Market: Product Outlook
4. Global Covid-19 Vaccine Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2020-2030
5. Global Covid-19 Vaccine Market Segmentation - By Product Type, Patient Type, End User
5.1 Competitive Scenario of Global Covid-19 Vaccine Market: By Product Type
5.1.1 Multivalent vaccine ñ Market Size and Forecast (2020-2030)
5.1.2 Monovalent Vaccine ñ Market Size and Forecast (2020-2030)
5.2 Competitive Scenario of Global Covid-19 Vaccine Market: By Patient Type
5.2.1 Paediatric ñ Market Size and Forecast (2020-2030)
5.2.2 Adult - Market Size and Forecast (2020-2030)
5.2.3 Senior Citizens ñ Market Size and Forecast (2020-2030)
5.3 Competitive Scenario of Global Covid-19 Vaccine Market : By End User
5.3.1 Hospitals - Market Size and Forecast (2020-2030)
5.3.2 Clinics - Market Size and Forecast (2020-2030)
5.3.3 Vaccination centers - Market Size and Forecast (2020-2030)
5.3.4 Academic and research Centers - Market Size and Forecast (2020-2030)
5.3.5 Others ñ Market Size and Forecast (2020-2030)

Direct Purchase of Global Covid-19 Vaccine Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=4298838

6. Global Covid-19 Vaccine Market: Regional Analysis
6.1 Competitive Scenario of Global Covid-19 Vaccine Market : By Region
7. North America Covid-19 Vaccine Market: An Analysis (2020-2030)
7.1 North America Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
7.2 North America Covid-19 Vaccine Market ñ Prominent Companies
7.3 Market Segmentation By Product Type (Multivalent Vaccine and Monovalent Vaccine)
7.4 Market Segmentation By Patient Type (Paediatric, Adult and Senior Citizens)
7.5 Market Segmentation By End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Centers, Others)
7.6 North America Covid-19 Vaccine Market: Country Analysis
7.7 Market Opportunity Chart of North America Covid-19 Vaccine Market - By Country, By Value, 2030
7.8 Competitive Scenario of North America Covid-19 Vaccine Market: By Country
7.9 United States Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
7.10 United States Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
7.11 Canada Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
7.12 Canada Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
8. Europe Covid-19 Vaccine Market: An Analysis (2020-2030)
8.1 Europe Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.2 Europe Covid-19 Vaccine Market - Prominent Companies
8.3 Market Segmentation By Product Type (Multivalent Vaccine and Monovalent Vaccine)
8.4 Market Segmentation By Patient Type (Paediatric, Adult and Senior Citizens)
8.5 Market Segmentation By End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Centers, Others)
8.6 Europe Covid-19 Vaccine Market: Country Analysis
8.7 Market Opportunity Chart Europe Covid-19 Vaccine Market - By Country, By Value, 2030
8.8 Competitive Scenario of Europe Covid-19 Vaccine Market: By Country
8.9 Germany Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.10 Germany Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
8.11 France Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.12 France Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
8.13 United Kingdom Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.14 United Kingdom Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
8.15 Switzerland Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.16 Switzerland Covid-19 Vaccine MarketSegmentation - By Product Type, By Patient Type, and By End User (2020-2030)
8.17 Russia Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
8.18 Russia Covid-19 Vaccine Market Segmentation - By Product Type, By Patient Type, and By End User (2020-2030)
9. Asia Pacific Covid-19 Vaccine Market: An Analysis (2020-2030)
9.1 Asia Pacific Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
9.2 Asia Pacific Covid-19 Vaccine Market - Prominent Companies
9.3 Market Segmentation By Product Type (Multivalent Vaccine and Monovalent Vaccine)
9.4 Market Segmentation By Patient Type (Paediatric, Adult and Senior Citizens)
9.5 Market Segmentation By End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Centers and Others)
9.6 Asia Pacific Covid-19 Vaccine Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Covid-19 Vaccine Market - By Country, By Value, 2030
9.8 Competitive Scenario of Asia Pacific Covid-19 Vaccine Market: By Country
9.9 China Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
9.10 China Covid-19 Vaccine Market Segmentation -By Product Type, By Patient Type, and By End User (2020-2030)
9.11 Japan Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
9.12 Japan Covid-19 Vaccine Market Segmentation ñ By Product Type, By Patient Type, and By End User (2020-2030)
9.13 India Covid-19 Vaccine Market: Size and Forecast (2020-2030), By Value
9.14 India Covid-19 Vaccine Market Segmentation -By Product Type, By Patient Type, and By End User (2020-2030)
10. Global Covid-19 Vaccine Market Dynamics
10.1 Drivers
10.2 Trends
10.3 Challenge
11. Market Attractiveness
11.1 Market Attractiveness Chart of Covid-19 Vaccine Market By Product Type, 2030
11.2 Market Attractiveness Chart of Covid-19 Vaccine Market - By Patient Type, 2030
11.3 Market Attractiveness Chart of Covid-19 Vaccine Market - By End User, 2030
11.4 Market Attractiveness Chart of Covid-19 Vaccine Market - By Region, 2030
12. Competitive Landscape
13. Major Technological Innovations, M&A, Role of Manufacturers during Pandemic
14. Covid-19 Vaccines: Cost and Effectiveness
15. Regulatory compliance
16. Company Profiles (Business Description, Financial Analysis, Business Strategy)
16.1 AstraZeneca Plc
16.2 Johnson & Johnson
16.3 Novavax
16.4 BioNTech
16.5 Moderna
16.6 Glaxo Smith Kline
16.7 CSL Ltd.
16.8 Abbott Laboratories
16.9 Daiichi Sankyo Company Ltd.
16.10 Astellas Pharma Inc.

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Covid-19 Vaccine Market Demands, Size and Key Players Analysis AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc. here

News-ID: 2265704 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion